SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors weigh recent record revenue growth against a headline net loss that was largely driven by non-cash accounting adjustments, sparking intense community debate over future regulatory catalysts and potential short-squeeze activity. The discourse is heavily focused on the company's global expansion plans, upcoming FDA milestones, and the persistent conflict between retail shareholders and market participants betting against the stock.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastly is currently experiencing extreme volatility following a significant post-earnings sell-off, despite the company reporting record revenue and raised guidance. Investors are actively debating whether this double-digit decline represents a buying opportunity due to strong long-term AI and edge computing prospects or if the stock is facing a deeper technical breakdown driven by algo-selling and momentum exhaustion.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is rallying as investors react to the strategic acquisition of Mirantis, which bolsters the company's AI cloud capabilities and provides a crucial software layer for enterprise clients. The community is heavily focused on the potential for imminent large-scale hyperscaler contracts and positive momentum leading into earnings, driving significant interest from both institutional and retail traders.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is experiencing significant volatility and trending among investors as the market reprices the stock following a turbulent period of regulatory hurdles and clinical trial updates. Community discussion is heavily divided between those scalping the stock for momentum-driven gains and skeptics who are raising concerns about the company's financial runway, potential dilution, and the unresolved outcomes of its regulatory path.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as investors aggressively position themselves ahead of the company's upcoming earnings, viewing the stock as a key infrastructure play in the AI supercycle. Community sentiment remains highly bullish, with active debate centered on the stock's massive momentum, ongoing short interest, and its perceived role as a critical data center bottleneck for hyperscalers.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is trending amid intense market volatility as investors weigh conflicting headlines surrounding a potential Iran peace deal and persistent broader uptrend dynamics. The community remains deeply polarized, with active debates between bears anticipating a technical pullback or crash and bulls aggressively buying intraday dips on the expectation of continued market support.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius Technologies is trending due to its recent securing of a major purchase order for its SiCore batteries from a new electric mobility customer, which has fueled investor optimism despite ongoing volatility. Community members are actively debating the company's long-term growth potential and warrant redemption structure, with many viewing recent price fluctuations as a strategic buying opportunity rather than a reflection of fundamental weakness.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as it relentlessly tests the $700 psychological level, with a polarized community split between bulls riding the AI-driven momentum and bears anticipating a blow-off top. Investors are actively debating the impact of ongoing geopolitical tensions in the Strait of Hormuz and potential shifts in interest rate expectations, keeping volume and volatility elevated.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is experiencing significant upward momentum as investors rally behind a blowout earnings report that highlights recovering margins and resilient demand for AI infrastructure. The community is heavily focused on the potential for a massive short squeeze, with many participants dismissing recent negative headlines and advocating for a long-term position to capitalize on the company's growth as a key player in the AI data center sector.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is experiencing significant market volatility as investors weigh record-breaking revenue and strong AI-driven licensing demand against concerns regarding supply chain bottlenecks and smartphone market contraction. The community is sharply divided, with bulls pointing to the company's long-term dominance in AI infrastructure and data center compute, while skeptics emphasize the stock's premium valuation and the executive team's cautious supply outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Tenax Therapeutics, Inc. (NASDAQ:TENX) Given Consensus Rating of "Moderate Buy" by Brokerages

Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a buy...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average   - Should You Sell?

Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200-Day Moving Average - What's Next...

Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat.com reports. One equities...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next?

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next...

Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average   - What's Next?

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell...

Cantor Fitzgerald Initiates Coverage on Tenax Therapeutics (NASDAQ:TENX)

Cantor Fitzgerald began coverage on shares of Tenax Therapeutics in a research report on Tuesday. They set an "overweight" rating and a $35.00 target price on the stock...

Boothbay Fund Management LLC Purchases Shares of 352,206 Tenax Therapeutics, Inc. $TENX

Boothbay Fund Management LLC acquired a new position in shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Free Report) in the third quarter, according to its most recent Form 13F filing with the...

Tenax Therapeutics (TENX) Expected to Announce Quarterly Earnings on Tuesday

Tenax Therapeutics (NASDAQ:TENX) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 24. (View Earnings Report at...

Guggenheim Issues Positive Forecast for Tenax Therapeutics (NASDAQ:TENX) Stock Price

Guggenheim raised their price target on shares of Tenax Therapeutics from $25.00 to $34.00 and gave the stock a "buy" rating in a report on Monday...

What is Lifesci Capital's Forecast for TENX Q1 Earnings?

Tenax Therapeutics, Inc. (NASDAQ:TENX - Free Report) - Equities researchers at Lifesci Capital issued their Q1 2026 earnings estimates for Tenax Therapeutics in a report released on Thursday, March...

Tenax Therapeutics, Inc. is a pharmaceutical company engaged in the development and commercialization of products for cardiovascular and pulmonary diseases. The company was founded on May 26, 1967 and is headquartered in Chapel Hill, NC.

TENX
Tenax Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Poll

Latest TENX News

TENXTenax Therapeutics Inc